Singapore: A dengue vaccine candidate developed by the National Institutes of Health (NIH) has shown to be safe and has ...
Singapore: The results of the phase III clinical trials of a malaria vaccine being developed by British pharmaceutical m...
Singapore: Sanofi announced that the phase III clinical trials for its dengue vaccine was successful, in a press confere...
Singapore: CSL Biotherapies has been awarded by the United States (US) Department of Health and Human Services to supply...
Mumbai: Serum Institute of India, the flagship company of the over $1 bn Poonawalla Group and India's largest vaccine co...
Singapore: Medicago, a biopharmaceutical company focused on developing highly effective and competitive vaccines based o...
Singapore: Hong Kong's Centre for Health Protection (CHP) and the provincial health department have reported eight new h...
Singapore: Researchers from the University of Sydney, have dismissed any link between development of autism and childho...
Singapore: Europe has established Glioma Actively Personalized Vaccine Consortium, (GAPVAC), a project designed to creat...
Dr Weidong Yin, the man behind Sinovac, was honoured with BioSpectrum Asia Pacific Bioscience Industry Entrepreneur of t...
New Delhi: India's second largest producer of vaccines, New Delhi-based Panacea Biotec, has received a government order ...
Singapore: Emergent BioSolutions has signed a license agreement with VaxInnate under which Emergent acquired the exclusi...
Singapore: Three cases of human infection with influenza A (H7N9) has erupted in China, notified China Health and Family...
Singapore: US Food and Drug Administration (FDA) has approved Flucelvax (Influenza Virus Vaccine), the first cell-cultur...
Singapore: LEO Pharma plans to establish five long-term, strategic research collaborations in four countries by the end ...
Singapore: The US Food and Drug Administration (FDA) has approved GlaxoSmithKline's vaccine MenHibrix (Meningococcal Gr...
Singapore: Australian infectious disease therapy and vaccine development company BioDiem has received notice of Allowanc...
Australian vaccine development company BioDiem Ltd has announced that it has begun research collaboration with Franc...
